Search results :

Finasteride

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: D11AX10, G04CB01

Side effects

Options: Show MedDRA Preferred Terms,   display all 38 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Infection 14.7% 15.5% x
Orthostatic hypotension 9.1% - 16.7% 8% x x x x x
Dizziness 7.4% - 17.7% 8.1% x x x x x
Asthenia 5.3% - 15.7% 7.1% x x x x x
Influenza 7.41% 7.71% x
Abnormal ejaculation 4.5% - 7.2% 2.3% x x x x x
Erectile dysfunction postmarketing, 1.3% - 18.5% 0.7% - 12.2% x x x x x x x x x x x x x x x x x x x x
Pharyngitis 4.76% 3.64% x
Sinusitis 3.81% 2.78% x
Bronchitis 2.75% 2.25% x
Somnolence 1.7% - 3.7% 1.5% x x x x x
Libido decreased postmarketing, 1.8% - 10% 1.3% - 5.7% x x x x x x x x x x x x x x x x x x x x
Pain 2.54% 2.46% x
Hypotension 1.2% - 3.4% 0.7% x x x x x
Headache 2% - 12.1% 2.3% - 10.3% x x x x x
Oedema peripheral 1.3% - 2.6% 0.9% x x x x x
Trauma 1.8% 2.25% x
Gynaecomastia 1.1% - 2.2% 0.7% x x x x x
Dyspnoea 0.7% - 2.1% 0.7% x x x x x
Rhinitis 1% - 1.3% 0.5% x x x x x
Breast enlargement 0.5% - 1.8% 0.1% - 1.1% x x x x x x x x x x x x x x x x
Ejaculation disorder postmarketing, 0.2% - 1.2% 0.1% - 0.7% x x x x x x x x x x x x x x x x x
Rash postmarketing, 0.5% 0.1% - 0.2% x x x x x x x x x x x x x x x x x x x x
Breast tenderness postmarketing, 0.4% - 0.7% 0.1% - 0.3% x x x x x x x x x x x x x x x x x x x
Angioedema postmarketing x x x
Mental disorder postmarketing x x x x x
Breast disorder postmarketing x x x x x x x x x x
Hypersensitivity postmarketing x x x x x x x x x x x x x x x x x x x x
Immune system disorder postmarketing x x x x x
Infertility male postmarketing x x x x x x x x x x x x
Neoplasm postmarketing x x x x x x x x x x x x x x x x
Orgasm abnormal postmarketing x x x x x x x
Pruritus postmarketing x x x x x x x x x x x x x x x x x x x x
Swelling postmarketing x x x x x x x x x x x x x x x x x x x x
Testicular pain postmarketing x x x x x x x x x x x x x x x x x x x
Urticaria postmarketing x x x x x x x x x x x x x x x x x x x x
Androgenetic alopecia postmarketing x x
Breast cancer male postmarketing x x x x x x x x x x x x x x x x
Sexual dysfunction postmarketing, 2% - 2.5% 0.9% x x x x x x x x x x x x
Breast cancer x x x x x x x x x x x x x x x x x x
Neoplasm malignant x
Musculoskeletal disorder x
Prostatic disorder x x
Neoplasm prostate x
Prostatic specific antigen increased x x x x x x x x x x
Tenderness x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

finasteride / Propecia

Side effects:10
Source:FDA

FINASTERIDE

Side effects:13
Source:FDA Structured Product Label

FINASTERIDE

Side effects:14
Source:FDA Structured Product Label

FINASTERIDE

Side effects:14
Source:FDA Structured Product Label

FINASTERIDE

Side effects:15
Source:FDA Structured Product Label

Finasteride tablets / Fintral, Tablet

Side effects:15
Source:Medsafe

finasteride / FINASTERIDE ALPHAPHARM

Side effects:18
Source:medicines.org.au

finasteride / Propecia, Film coated tablet

Side effects:18
Source:Medsafe

FINASTERIDE

Side effects:19
Source:FDA Structured Product Label

FINASTERIDE

Side effects:19
Source:FDA Structured Product Label

Finasteride

Side effects:19
Source:FDA Structured Product Label

FINASTERIDE

Side effects:20
Source:FDA Structured Product Label

FINASTERIDE

Side effects:20
Source:FDA Structured Product Label

finasteride / Proscar

Side effects:24
Source:FDA

FINASTERIDE / PROSCAR

Side effects:25
Source:Health Canada

FINASTERIDE

Side effects:27
Source:FDA Structured Product Label

(finasteride) Tablets / PROPECIA

Side effects:28
Source:medicines.org.au

FINASTERIDE

Side effects:29
Source:FDA Structured Product Label

FINASTERIDE

Side effects:30
Source:FDA Structured Product Label

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label